GeneNews' Q3 Revenues Dip on Lower Licensing Revenues | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneNews reported after the close of the market Monday that its third-quarter revenues dropped more than 50 percent on lower licensing revenue year over year.

The Toronto-based firm brought in total revenues of C$166,515 (US$163,309) for the three-month period ended Sept. 30, compared to C$362,964 for the third quarter of 2009. Its license revenue declined to C$162,619 from C$311,684 year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.